Inactivated sendai virus
WebDec 8, 2015 · Inactivated Sendai virus (hemagglutinating virus of Japan; HVJ) envelope (HVJ-E) induces anticancer immunity and cancer cell-selective apoptosis through the recognition of viral RNA genome fragments by retinoic acid-inducible gene-I (RIG-I). WebJul 20, 2011 · We have developed a hemagglutinating virus of Japan envelope (HVJ-E) vector by using inactivated Sendai virus as a pseudovirion for gene and drug delivery . …
Inactivated sendai virus
Did you know?
Web2.4.1.4Ability of Sendai virus to inhibit interferon response in some cancer cells 2.4.1.5Activation of a necroptotic pathway in malignant cells 2.4.1.6Virus, mediated fusion of cancer cells, kills them faster 2.4.2Killing of malignant cells by virus triggered anti-tumor immunity 2.4.2.1Stimulation of the secretion of cytokines 2.4.2.1.1Interferons WebApr 1, 2024 · In this study, we characterized for the first time that HVJ-E induced both apoptosis and autophagy in PC3 cells and that induction of apoptosis and autophagy by …
WebSendai virus was first isolated by Kuroya et al. (1953) in 1952 and was described clinically by Sano et al. (1953) and pathologically by Noda (1953) during an outbreak of … WebDec 4, 2024 · In recent years, inactivated Sendai virus particles (hemagglutinating virus of Japan envelope, HVJ-E) have been shown to contribute to several anti-cancer effects, such as the activation of anti-tumor immunity via anti-tumorigenic neutrophils in the tumor microenvironment , the suppression of murine melanoma growth by host immune …
WebJul 20, 2011 · HVJ envelope (HVJ-E) was constructed by inactivation of HVJ (hemagglutinating virus of Japan; Sendai virus) with ß-propiolactone (0.0075% - 0.001%) or UV irradiation (99 mjoule/cm 2 ), as described previously, and then purified by ion-exchange column chromatography and gel filtration. WebSep 5, 2013 · Background: Ultraviolet-inactivated, replication-defective Sendai virus particles (Z strain) have displayed antitumor effect through enhancing the immune responses or …
WebFeb 23, 2024 · Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 67 (1), 227–236. Article CAS PubMed Google Scholar Fujihara A., Kurooka M., Miki T., Kaneda Y. 2008. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by …
WebDuring fusion between the donor cell and the enucleated oocyte, electrofusion triggers spontaneous oocyte activation, accompanied by an increase in intracellular Ca 2+ and improper nuclear remodelling. These events can be greatly reduced by the use of Sendai virus (SV)-mediated fusion. phillip howell openworkWebfrom publication: Enhancement of Sendai virus-mediated cell fusion by cupric ions The effect of divalent cations on cell fusion by concentrated Sendai virus, inactivated by beta-propiolactone ... phillip howard attorneyWebDec 1, 2014 · We previously reported that inactivated Sendai virus (hemagglutinating virus of Japan; HVJ) envelope (HVJ-E) activates anti-tumor immunity and induces cancer cell … tryordWebJan 1, 1979 · This chapter discusses the preparation of Sendai virus for cell fusion. Positive allantoic fluids are pooled aseptically and clarified of urates and cell debris by centrifuging. ... The inactivated virus is diluted to 4000 HAU/ml with Earle's BSS (2 parts virus + 3 parts BSS), ampuled in 1.1-ml lots, snap-frozen in a mixture of solid CO 2 and ... try or install zorin os safe graphicsWebAug 6, 2024 · Inactivated Sendai virus particle (or hemagglutinating virus of Japan envelope; HVJ-E) has been previously reported to possess antitumour properties that … try or triedWebJul 20, 2011 · We found that inactivated Sendai virus particle (HVJ-E) induced extensive cell death in the human glioblastoma cell line U251MG. Intradermal U251MG tumors were more effectively suppressed by HVJ-E ... tryo shopWebApr 1, 1995 · Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. The Journal of Immunology American Association of Immunologists Volume 154, Issue 7 1 April 1995 Research Article April 01 1995 phillip howell pastor